Methotrexate

GO-DACT: a phase 3b randomised, double-blind, placebo-controlled trial of GOlimumab plus methotrexate (MTX) versus placebo plus MTX in improving DACTylitis in MTX-naive patients with psoriatic arthritis
Elsa Vieira-Sousa, Pedro Alves, Ana M Rodrigues, Filipa Teixeira, Jose Tavares-Costa, Alexandra Bernardo, Sofia Pimenta, Fernando M Pimentel-Santos, João Lagoas Gomes, Renata Aguiar, Patrícia Pinto, Taciana Videira, Cristina Catita, Helena Santos, Joana Borges, Graça Sequeira, Célia Ribeiro, Lídia Teixeira, Pedro Ávila- Ribeiro, Fernando M Martins, Helena Canhão, Iain B. McInnes, Ruy M Ribeiro, João Eurico Fonseca

Annals of the Rheumatic Diseases Apr 2020, 79 (4) 490-498; DOI: 10.1136/annrheumdis-2019-216500
LACC1 gene mutation in three sisters with polyarthritis without systemic features
Ankita Singh, Deepti Suri, Pandiarajan Vignesh, Gummadi Anjani, Prince Jacob, Katta M Girisha

Annals of the Rheumatic Diseases Mar 2020, 79 (3) 425-426; DOI: 10.1136/annrheumdis-2019-216263
Error in the dosage of Methotrexate in the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
Dennis Scheicht

Annals of the Rheumatic Diseases Feb 2020, annrheumdis-2020-217041; DOI: 10.1136/annrheumdis-2020-217041
Rapid induction of clinical remission by immunoadsorption for refractory lupus retinopathy complicated with life-threatening neuropsychiatric lupus
Guangfeng Zhang, Xiao Zhang, Yunfei Chai, Siwen Zang, Yunzhen Shi, Haijun Wu

Annals of the Rheumatic Diseases Feb 2020, 79 (2) 302-304; DOI: 10.1136/annrheumdis-2019-215930
Metering the METEOR in methotrexate failure: is propensity score a falling star?
Sakir Ahmed

Annals of the Rheumatic Diseases Dec 2019, 78 (12) e131; DOI: 10.1136/annrheumdis-2018-214612
Response to: ‘Metering the METEOR in methotrexate failure: is propensity score a falling star?’ by Ahmed et al
Sytske Anne Bergstra, Cornelia F Allaart, Robert B M Landewé

Annals of the Rheumatic Diseases Dec 2019, 78 (12) e132; DOI: 10.1136/annrheumdis-2018-214652
Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response
Roy M Fleischmann, Mark C Genovese, Jeffrey V Enejosa, Eduardo Mysler, Louis Bessette, Charles Peterfy, Patrick Durez, Andrew Ostor, Yihan Li, In-Ho Song

Annals of the Rheumatic Diseases Nov 2019, 78 (11) 1454-1462; DOI: 10.1136/annrheumdis-2019-215764
Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase III randomised, double-blind, placebo-controlled trial (RAJ4) in Japan
Tsutomu Takeuchi, Yoshiya Tanaka, Sakae Tanaka, Atsushi Kawakami, Manabu Iwasaki, Kou Katayama, Mitsuhiro Rokuda, Hiroyuki Izutsu, Satoshi Ushijima, Yuichiro Kaneko, Teruaki Shiomi, Emi Yamada, Désirée van der Heijde

Annals of the Rheumatic Diseases Oct 2019, 78 (10) 1305-1319; DOI: 10.1136/annrheumdis-2019-215164
Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials
Maxime MA Verhoeven, Marjolein JH de Hair, Janneke Tekstra, Johannes WJ Bijlsma, Jacob M van Laar, Attila Pethoe-Schramm, Michelle EA Borm, Evert-Jan ter Borg, Suzanne P Linn-Rasker, Xavier M Teitsma, Floris PJG Lafeber, Johannes WG Jacobs, Paco MJ Welsing

Annals of the Rheumatic Diseases Oct 2019, 78 (10) 1333-1338; DOI: 10.1136/annrheumdis-2019-215304
Development and validation of a methotrexate adherence assay
James Bluett, Isabel Riba-Garcia, Suzanne M M Verstappen, Thierry Wendling, Kayode Ogungbenro, Richard D Unwin, Anne Barton

Annals of the Rheumatic Diseases Sep 2019, 78 (9) 1192-1197; DOI: 10.1136/annrheumdis-2019-215446

Main menu

Methotrexate

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Methotrexate

Pages